| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |